At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and the world.
![]() |
Fred Appelbaum, director of the Clinical Research Division When Appelbaum was a medical student, he happened upon an early write-up of bone-marrow transplantation by Dr. E. Donnall Thomas, who later won a Nobel Prize for the pioneering blood-cancer treatment. Little did he know that one day he'd have Thomas' job at the Hutchinson Center. Read more » |
![]() |
Colleen Delaney, cord blood transplant program director By harnessing the healing power of umbilical cord blood, Delaney is on the forefront of developing a treatment that may prove to be a landmark breakthrough for deperately ill leukemia patients. Read more » |
![]() |
Dan Gottschling, cell biologist By turning to tiny yeast cells for clues, Gottschling is trying to get a better grasp on a problem that has long vexed biologists: the relationship between cancer and aging. Read more » |
![]() |
Mark Groudine, deputy director of the Hutchinson Center Mark Groudine says he's "not at all a top down kind of leader – I give people responsibility and turn them loose." Meanwhile, his own research as an award-winning molecular and cellular biologist has earned him international renown. Read more » |
![]() |
M. Elizabeth Halloran and Ira Longini, biostaticians Halloran and Longini are considered among the world’s foremost researchers on the spread of infectious diseases. They collaborate on powerful computer models that simulate the path of scourges like pandemic flu and advise health leaders around the globe. Read more » |
![]() |
Steve Henikoff, geneticist and inventor Renowned for his genetic research, Henikoff has developed widely used computer programs and a wealth of other research tools that have led to breakthroughs in many areas of basic science. Read more » |
![]() |
Sunil Hingorani, pancreatic-cancer researcher Hingorani's work has yielded one of the most significant advances in decades related to early detection and treatment of pancreatic cancer, a disease that is almost uniformly a death sentence by the time it is detected. Read more » |
Harmit Malik and Michael Emerman, biologists Longtime collaboration between Malik and Emerman has led to important discoveries about the evolutionary struggle between viruses and humans. Ultimately, they hope their research may lead to new drugs to fight HIV. Read more » | |
![]() |
Julie McElrath, HIV vaccine researcher As one of the leaders of a massive international effort to develop a preventive vaccine for HIV, McElrath has spent more than two decades at the forefront of the war on AIDS. Read more » |
![]() |
Anne McTiernan, cancer prevention researcher McTiernan's groundbreaking studies have produced some of the first specific answers about the role of exercise and weight loss in reducing cancer risk, earning her a spot on a federal advisory committee. Read more » |
![]() |
Elahe Mostaghel, oncologist and cancer researcher Mostaghel works to improve our understanding of what makes cancer treatments successful and how best to target them to patients, with a focus on prostate cancer. Read more » |
![]() |
Richard Nash, immunotherapy researcher and oncologist Nash's research focuses on whether bone-marrow or stem-cell transplantation, the standard therapy for leukemia and other blood cancers, could also work for autoimmune diseases like multiple sclerosis and lupus, which have puzzled doctors for decades. Read more » |
![]() |
J. Lee Nelson, autoimmunity researcher and rheumatologist Nelson's pioneering work on the mother-child cell transfer that happens during pregnancy, known as microchimerism, could form the basis for new therapies for people with autoimmune diseases like rheumatoid arthritis, scleroderma and diabetes. Read more » |
![]() |
Patrick Paddison, geneticist Employing a cutting-edge technology called RNA interference, Paddison investigates why cells behave in particular ways--work that could lead to better therapies for many diseases. Read more » |
![]() |
Amanda Paulovich, oncologist and cancer geneticist Paulovich's lab develops technologies aimed at rapidly screening large numbers of telltale proteins — known as "biomarkers" — for clues that may indicate the earliest stages of cancer and other diseases. Read more » |
![]() |
Katie Peichel, geneticist By examining the evolution of body type and behavior in stickleback fish, Peichel works to shed light on the genetic networks at play in other complex traits, such as cancer and other common human diseases. Read more » |
![]() |
Scott Ramsey, physician, cancer researcher and health economist When Ramsey talks about medicine, his upturned palms often rise to form an imaginary scale. As a physician, cancer researcher and health economist, he weighs the cost and benefit of various treatments, doggedly advocating for the best patient care for the least amount of money. Read more » |
![]() |
Stanley Riddell, immunotherapy researcher and oncologist Riddell is working to fortify cancer patients' immune systems with special, long-living T-cells engineered to seek and destroy their disease. He hopes to move the treatment technique into clinics in the near future. Read more » |
![]() |
Jim Roberts, director of Basic Sciences Division Whether researching cell processes that lead to cancer, recruiting scientists for the division he leads, or riding his bike, Roberts has a penchant for the road less traveled. Read more » |
![]() |
Mark Roth, cell biologist Growing up in an orphanage in Hershey, Pa., Roth often heard "no" from the adults in his life. No, he couldn't run on the high-school track or cross-country teams. No, he'd never be a scientist. Now his research may one day transform emergency medicine. Read more » |
![]() |
Nina Salama, microbiologist Salama's research focuses on better understanding the genetics of a bacterium called H. pylori, which has been linked to gastric-cancer development. Read more » |
![]() |
Janet Stanford, director of Program in Prostate Cancer Research The hope of cancer prevention motivates Stanford on a very personal level. Five of her close family members have fought the disease. "I look at my son," she says, "and I am inspired to do something to prevent him from getting prostate cancer like both of his grandfathers." Read more » |
![]() |
Rainer Storb, head of Transplantation Biology Program Storb continues to be on the forefront of developing new blood-cancer treatments after working on team led by Dr. E. Donnall Thomas, who pioneered bone marrow transplantation. Much of what scientists have learned — and are still learning — about the biology of stem-cell transplantation came from Storb's laboratory. Read more » |
![]() |
Toshiyasu Taniguchi, oncologist and cancer biologist Taniguchi delves into a natural process called DNA repair to shed light on a phenomenon that has long vexed oncologists: why anti-cancer drugs often decline in effectiveness over time. Read more » |
![]() |
Muneesh Tewari, oncologist and cancer researcher Like many brainy Detroit kids who excelled in math and science, Tewari figured he'd become an engineer at one of the auto plants that ruled the local economy. But when his high-school biology teacher got him a summer job at a cancer-center laboratory, tinkering with automobile engines didn't seem so interesting anymore. Read more » |
![]() |
Barb Trask, director of Human Biology Division In addition to supporting new and established scientists in her division, Trask delves into how our genes are organized. Her work could one day help doctors to develop more precise diagnostic tools, design new treatments, or provide better advice about lifestyle and health-care choices based on a patient's own DNA. Read more » |
![]() |
Cassian Yee, immunotherapy researcher Yee is on the cutting edge of a medical field called adoptive immunotherapy, which he has used to fight advanced skin cancer by harnessing a patient's own infection-fighting T-cells to seek and destroy tumor cells. Read more » |